ATXS
Price
$6.41
Change
+$0.21 (+3.39%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
361.74M
33 days until earnings call
CABA
Price
$1.50
Change
+$0.01 (+0.67%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
135.81M
29 days until earnings call
Interact to see
Advertisement

ATXS vs CABA

Header iconATXS vs CABA Comparison
Open Charts ATXS vs CABABanner chart's image
Astria Therapeutics
Price$6.41
Change+$0.21 (+3.39%)
Volume$9.35K
Capitalization361.74M
Cabaletta Bio
Price$1.50
Change+$0.01 (+0.67%)
Volume$15K
Capitalization135.81M
ATXS vs CABA Comparison Chart in %
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. CABA commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Buy and CABA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (ATXS: $6.41 vs. CABA: $1.51)
Brand notoriety: ATXS and CABA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 70% vs. CABA: 71%
Market capitalization -- ATXS: $361.74M vs. CABA: $135.81M
ATXS [@Biotechnology] is valued at $361.74M. CABA’s [@Biotechnology] market capitalization is $135.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileCABA’s FA Score has 1 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • CABA’s FA Score: 1 green, 4 red.
According to our system of comparison, CABA is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 5 TA indicator(s) are bullish while CABA’s TA Score has 3 bullish TA indicator(s).

  • ATXS’s TA Score: 5 bullish, 4 bearish.
  • CABA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than CABA.

Price Growth

ATXS (@Biotechnology) experienced а +18.05% price change this week, while CABA (@Biotechnology) price change was -3.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

ATXS is expected to report earnings on Nov 12, 2025.

CABA is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($362M) has a higher market cap than CABA($136M). ATXS YTD gains are higher at: -28.300 vs. CABA (-33.480). CABA (-123.92M) and ATXS (-124.4M) have comparable annual earnings (EBITDA) . ATXS has more cash in the bank: 295M vs. CABA (132M). ATXS has less debt than CABA: ATXS (5.06M) vs CABA (28.8M). ATXS (0) and CABA (0) have equivalent revenues.
ATXSCABAATXS / CABA
Capitalization362M136M266%
EBITDA-124.4M-123.92M100%
Gain YTD-28.300-33.48085%
P/E RatioN/AN/A-
Revenue00-
Total Cash295M132M223%
Total Debt5.06M28.8M18%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSCABA
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 6 days ago
87%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UPCHY116.84N/A
N/A
Uni-President China Holdings Ltd.
KRBPQ0.10N/A
N/A
Kiromic BioPharma Inc
INFT11.65N/A
N/A
Infinity Bancorp
STOSF5.04N/A
N/A
Santos Ltd.
KWTEF15.43N/A
N/A
KIWETINOHK ENERGY CORP

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with XENE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
+3.39%
XENE - ATXS
53%
Loosely correlated
-1.29%
CRNX - ATXS
53%
Loosely correlated
+1.07%
DNLI - ATXS
52%
Loosely correlated
+0.56%
ERAS - ATXS
52%
Loosely correlated
+2.82%
COGT - ATXS
52%
Loosely correlated
+4.60%
More

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with IPSC. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
+1.34%
IPSC - CABA
43%
Loosely correlated
+2.25%
KYTX - CABA
43%
Loosely correlated
+10.59%
ARCT - CABA
43%
Loosely correlated
+3.29%
RNA - CABA
41%
Loosely correlated
+1.56%
OCUL - CABA
41%
Loosely correlated
+3.23%
More